2023 Q2 Form 10-Q Financial Statement

#000095017023015249 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $145.2M $146.0M $147.7M
YoY Change 0.14% -1.15% 15.0%
Cost Of Revenue $94.44M $94.34M $93.36M
YoY Change 1.4% 1.06% 8.76%
Gross Profit $50.74M $51.65M $54.34M
YoY Change -2.13% -4.95% 27.59%
Gross Profit Margin 34.95% 35.38% 36.79%
Selling, General & Admin $23.69M $21.98M $21.79M
YoY Change 6.55% 0.88% 18.9%
% of Gross Profit 46.7% 42.55% 40.1%
Research & Development $6.721M $6.586M $6.194M
YoY Change 6.78% 6.33% 8.92%
% of Gross Profit 13.25% 12.75% 11.4%
Depreciation & Amortization $7.257M $6.918M $4.368M
YoY Change 3.44% 58.38% -35.76%
% of Gross Profit 14.3% 13.39% 8.04%
Operating Expenses $30.42M $28.57M $27.98M
YoY Change 6.6% 2.08% 16.53%
Operating Profit $20.33M $22.18M $26.36M
YoY Change -10.4% -15.87% 42.49%
Interest Expense $254.0K $694.0K -$366.0K
YoY Change -57.81% -289.62% -165.95%
% of Operating Profit 1.25% 3.13% -1.39%
Other Income/Expense, Net -$2.606M $534.0K $66.00K
YoY Change -54.79% 709.09% -101.78%
Pretax Income $16.08M $22.71M $25.75M
YoY Change -4.98% -11.8% 74.09%
Income Tax $3.183M $4.365M $5.507M
% Of Pretax Income 19.79% 19.22% 21.39%
Net Earnings $12.90M $18.34M $20.24M
YoY Change 2.37% -9.36% 68.8%
Net Earnings / Revenue 8.88% 12.56% 13.7%
Basic Earnings Per Share $0.41 $0.58 $0.63
Diluted Earnings Per Share $0.41 $0.58 $626.1K
COMMON SHARES
Basic Shares Outstanding 31.54M 31.67M 32.12M
Diluted Shares Outstanding 31.69M 31.89M 32.33M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.9M $143.5M $126.1M
YoY Change 52.8% 13.81% 21.97%
Cash & Equivalents $150.9M $143.5M $126.1M
Short-Term Investments
Other Short-Term Assets $18.92M $17.93M $18.37M
YoY Change 13.29% -2.37% 30.12%
Inventory $62.56M $63.47M $52.45M
Prepaid Expenses
Receivables $97.52M $97.71M $95.11M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $329.9M $322.6M $292.0M
YoY Change 18.43% 10.48% 18.41%
LONG-TERM ASSETS
Property, Plant & Equipment $120.7M $96.28M $97.04M
YoY Change 21.16% -0.78% 2.31%
Goodwill $155.9M $155.7M $117.5M
YoY Change 11.68% 32.44% 7.36%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $40.66M $17.61M $75.08M
YoY Change 110.73% -76.54% 2941.94%
Total Long-Term Assets $426.0M $424.4M $392.7M
YoY Change -5.55% 8.06% 1.2%
TOTAL ASSETS
Total Short-Term Assets $329.9M $322.6M $292.0M
Total Long-Term Assets $426.0M $424.4M $392.7M
Total Assets $755.9M $747.0M $684.7M
YoY Change 3.6% 9.09% 7.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.12M $53.41M $60.01M
YoY Change -12.43% -11.0% 12.56%
Accrued Expenses $29.33M $36.53M $38.55M
YoY Change -18.92% -5.24% 2.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $107.2M $105.8M $115.0M
YoY Change -7.1% -8.05% 7.81%
LONG-TERM LIABILITIES
Long-Term Debt $77.04M $80.26M $50.00M
YoY Change -15.37% 60.52% 0.0%
Other Long-Term Liabilities $34.51M $5.223M $33.66M
YoY Change 1090.79% -84.48% 640.33%
Total Long-Term Liabilities $111.5M $5.223M $83.66M
YoY Change 3749.17% -93.76% 1739.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $107.2M $105.8M $115.0M
Total Long-Term Liabilities $111.5M $5.223M $83.66M
Total Liabilities $234.5M $232.9M $204.6M
YoY Change -3.77% 13.84% 2.82%
SHAREHOLDERS EQUITY
Retained Earnings $575.4M $563.8M
YoY Change 10.13%
Common Stock $362.6M $361.2M
YoY Change 0.98%
Preferred Stock
YoY Change
Treasury Stock (at cost) $420.3M $411.6M
YoY Change 6.96%
Treasury Stock Shares $25.85M $25.18M
Shareholders Equity $521.4M $514.1M $480.2M
YoY Change
Total Liabilities & Shareholders Equity $755.9M $747.0M $684.7M
YoY Change 3.6% 9.09% 7.89%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $12.90M $18.34M $20.24M
YoY Change 2.37% -9.36% 68.8%
Depreciation, Depletion And Amortization $7.257M $6.918M $4.368M
YoY Change 3.44% 58.38% -35.76%
Cash From Operating Activities $23.42M $11.19M $19.29M
YoY Change 45.78% -42.0% -4.1%
INVESTING ACTIVITIES
Capital Expenditures $3.947M $4.540M -$3.400M
YoY Change -209.91% -233.53% 112.5%
Acquisitions $3.356M $24.48M
YoY Change -86.29%
Other Investing Activities -$3.000K -$3.356M -$24.48M
YoY Change -100.0% -86.29%
Cash From Investing Activities -$3.950M -$7.896M -$27.88M
YoY Change -94.78% -71.68% 1602.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.34M -16.63M -6.772M
YoY Change -142.81% 145.5% -7.14%
NET CHANGE
Cash From Operating Activities 23.42M 11.19M 19.29M
Cash From Investing Activities -3.950M -7.896M -27.88M
Cash From Financing Activities -13.34M -16.63M -6.772M
Net Change In Cash 6.129M -13.37M 19.29M
YoY Change -121.58% -169.34% 65.99%
FREE CASH FLOW
Cash From Operating Activities $23.42M $11.19M $19.29M
Capital Expenditures $3.947M $4.540M -$3.400M
Free Cash Flow $19.47M $6.646M $22.69M
YoY Change -0.93% -70.7% 4.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000026058
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-4639
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CTS CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IN
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-0225010
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4925 Indiana Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Lisle
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60532
CY2023Q1 dei City Area Code
CityAreaCode
630
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
577-8800
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, without par value
CY2023Q1 dei Trading Symbol
TradingSymbol
CTS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31540012
CY2023Q1 us-gaap Revenues
Revenues
145994000
CY2022Q1 us-gaap Revenues
Revenues
147695000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94342000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
93355000
CY2023Q1 us-gaap Gross Profit
GrossProfit
51652000
CY2022Q1 us-gaap Gross Profit
GrossProfit
54340000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21979000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21788000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6586000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6194000
CY2023Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
912000
CY2022Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
312000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22175000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
26046000
CY2023Q1 us-gaap Interest Expense
InterestExpense
694000
CY2022Q1 us-gaap Interest Expense
InterestExpense
546000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1063000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
180000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
165000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
66000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
534000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-300000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22709000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25746000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4365000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5507000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
18344000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
20239000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31634000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32123000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
259000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
204000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31893000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32327000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.04
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.04
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
18344000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
20239000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
379000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1235000
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
34000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-94000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1024000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-249000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1369000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1080000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19713000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21319000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143537000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156910000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
97707000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90935000
CY2023Q1 us-gaap Inventory Net
InventoryNet
63470000
CY2022Q4 us-gaap Inventory Net
InventoryNet
62260000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
17930000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
15655000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
322644000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
325760000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
96280000
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
908979000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97300000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21869000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22702000
CY2023Q1 us-gaap Goodwill
Goodwill
155651000
CY2022Q4 us-gaap Goodwill
Goodwill
152361000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
109706000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
108053000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
23246000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
23461000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17611000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18850000
CY2023Q1 cts Other Assets Noncurrent Excluding Property Plant And Equipment Net And Operating Lease Assets Net
OtherAssetsNoncurrentExcludingPropertyPlantAndEquipmentNetAndOperatingLeaseAssetsNet
306214000
CY2022Q4 cts Other Assets Noncurrent Excluding Property Plant And Equipment Net And Operating Lease Assets Net
OtherAssetsNoncurrentExcludingPropertyPlantAndEquipmentNetAndOperatingLeaseAssetsNet
302725000
CY2023Q1 us-gaap Assets
Assets
747007000
CY2022Q4 us-gaap Assets
Assets
748487000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
53410000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
53211000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4032000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3936000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11800000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20063000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36534000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35322000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
105776000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
112532000
CY2023Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
80261000
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
83670000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20808000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21754000
CY2023Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
5017000
CY2022Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
5048000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15786000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16010000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5223000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3249000
CY2023Q1 us-gaap Liabilities
Liabilities
232871000
CY2022Q4 us-gaap Liabilities
Liabilities
242263000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
318785000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
316803000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42423000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46144000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
563787000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
546703000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
698000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-671000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
411557000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
402755000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
514136000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
506224000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
747007000
CY2023Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
925693000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
748487000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
18344000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
20239000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6918000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6749000
CY2023Q1 cts Pension And Other Postretirement Expense Income
PensionAndOtherPostretirementExpenseIncome
31000
CY2022Q1 cts Pension And Other Postretirement Expense Income
PensionAndOtherPostretirementExpenseIncome
91000
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
1586000
CY2022Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
1950000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-236000
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1195000
CY2023Q1 us-gaap Gain Loss On Foreign Currency Cash Flow Hedge Ineffectiveness
GainLossOnForeignCurrencyCashFlowHedgeIneffectiveness
-192000
CY2022Q1 us-gaap Gain Loss On Foreign Currency Cash Flow Hedge Ineffectiveness
GainLossOnForeignCurrencyCashFlowHedgeIneffectiveness
15000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5906000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9969000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
784000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
615000
CY2023Q1 cts Increase Decrease In Operating Right Of Use Asset
IncreaseDecreaseInOperatingRightOfUseAsset
-833000
CY2022Q1 cts Increase Decrease In Operating Right Of Use Asset
IncreaseDecreaseInOperatingRightOfUseAsset
224000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
133000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
253000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
857000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3936000
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-8818000
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-5733000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-851000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
93000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-797000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2219000
CY2023Q1 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-50000
CY2022Q1 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-377000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11186000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19286000
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4540000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3400000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3356000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
24484000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7896000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27884000
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
204084000
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
150000000
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
200675000
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
150000000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8802000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3920000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1272000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1289000
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
150000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3142000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1413000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16625000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6772000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-38000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13373000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15347000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
156910000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
141465000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
143537000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
126118000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
926000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
480000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4199000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2548000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1400000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1339000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
506224000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
18344000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
379000
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
34000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1024000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.04
CY2023Q1 us-gaap Dividends
Dividends
1260000
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
198271
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8802000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3143000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1404000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
514136000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
463578000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
20239000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1235000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-94000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-249000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.04
CY2022Q1 us-gaap Dividends
Dividends
1284000
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
116176
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3920000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1413000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1898000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
480178000
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-154
CY2023Q1 us-gaap Goodwill
Goodwill
155651000
CY2023Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTE 1 — Basis of Presentation</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying condensed consolidated financial statements have been prepared by CTS Corporation (“CTS”, "we", "our", "us" or the "Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the financial statements, notes thereto, and other information included in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements reflect, in the opinion of management, all adjustments (consisting of normal recurring items) necessary for a fair statement, in all material respects, of the financial position and results of operations for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates. The results of operations for the interim periods are not necessarily indicative of the results for the entire year.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There have been no material changes in the Company’s significant accounting policies as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.</span></p></div>
CY2023Q1 us-gaap Revenues
Revenues
145994000
CY2022Q1 us-gaap Revenues
Revenues
147695000
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
98797000
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
92171000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1090000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1236000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
97707000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90935000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13428000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12865000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
21892000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
22819000
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
39504000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
37362000
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
11354000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
10786000
CY2023Q1 us-gaap Inventory Net
InventoryNet
63470000
CY2022Q4 us-gaap Inventory Net
InventoryNet
62260000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
236813000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
233897000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
96280000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97300000
CY2023Q1 us-gaap Depreciation
Depreciation
4407000
CY2022Q1 us-gaap Depreciation
Depreciation
4368000
CY2022Q4 us-gaap Goodwill
Goodwill
152361000
CY2023Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
3444
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2092000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2368000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
195923000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
86217000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
109706000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2511000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194154000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
86101000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
108053000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2381000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8449000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10959000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
10482000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
10328000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10270000
CY2023Q1 cts Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
59218000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
109706000
CY2023Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
912000
CY2022Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
312000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
869000
CY2023Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
912000
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
681000
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
1100000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9210000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9630000
CY2023Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
2279000
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
2142000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1587000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1472000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2648000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2837000
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
1263000
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1272000
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
11058000
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
11048000
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
649000
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
357000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5748000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4196000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36534000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35322000
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
11048000
CY2021Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
10979000
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies Charges To Expense For New Losses
AccrualForEnvironmentalLossContingenciesChargesToExpenseForNewLosses
562000
CY2022 us-gaap Accrual For Environmental Loss Contingencies Charges To Expense For New Losses
AccrualForEnvironmentalLossContingenciesChargesToExpenseForNewLosses
2750000
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
555000
CY2022 us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
2661000
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies Foreign Currency Translation Gain Loss
AccrualForEnvironmentalLossContingenciesForeignCurrencyTranslationGainLoss
3000
CY2022 us-gaap Accrual For Environmental Loss Contingencies Foreign Currency Translation Gain Loss
AccrualForEnvironmentalLossContingenciesForeignCurrencyTranslationGainLoss
-20000
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
11058000
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
11048000
CY2023Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
400000000
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
400000000
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1640000
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1640000
CY2023Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
318099000
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
116176
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
98536
CY2022Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
60683
CY2022Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
314690000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48000
CY2023Q1 us-gaap Derivative Net Hedge Ineffectiveness Gain Loss
DerivativeNetHedgeIneffectivenessGainLoss
0
CY2023Q1 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
2123000
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
756000
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
317000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
68
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
288
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57429297
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57330761
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31581155
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31680890
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
25848142
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
25649871
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
198271
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8802000
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
116176
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3920000
CY2023Q1 cts Common Stock Capital Shares Availablefor Future Purchases Value
CommonStockCapitalSharesAvailableforFuturePurchasesValue
45399000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31680890
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32178715
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
198271
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31581155
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32123222
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37676
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38384
CY2023Q1 cts Number Of Equity Based Compensation Plan
NumberOfEquityBasedCompensationPlan
5
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.192
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.214

Files In Submission

Name View Source Status
cts-20230331_cal.xml Edgar Link unprocessable
cts-20230331_def.xml Edgar Link unprocessable
0000950170-23-015249-index-headers.html Edgar Link pending
0000950170-23-015249-index.html Edgar Link pending
0000950170-23-015249.txt Edgar Link pending
0000950170-23-015249-xbrl.zip Edgar Link pending
cts-20230331.htm Edgar Link pending
cts-20230331.xsd Edgar Link pending
cts-ex10_a.htm Edgar Link pending
cts-ex10_b.htm Edgar Link pending
cts-ex10_c.htm Edgar Link pending
cts-ex10_d.htm Edgar Link pending
cts-ex10_e.htm Edgar Link pending
cts-ex31_a.htm Edgar Link pending
cts-ex31_b.htm Edgar Link pending
cts-ex32_a.htm Edgar Link pending
cts-ex32_b.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
cts-20230331_lab.xml Edgar Link unprocessable
cts-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cts-20230331_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending